Fidelity Investments’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Fidelity Investments’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-448,539	Closed	-$78.3K	–	5692
2023 Q1	$78.3K	Sell	448,539 -4,157,054	-90%	-$2.31M	﹤0.01%	3279
2022 Q4	$1.83M	Buy	4,605,593 +125,159	+3%	+$82.4K	﹤0.01%	2399
2022 Q3	$3.5M	Buy	4,480,434 +1,106,420	+33%	+$2.32M	﹤0.01%	2271
2022 Q2	$9.72M	Buy	3,374,014 +18,675	+0.6%	+$65.6K	﹤0.01%	1977
2022 Q1	$21M	Buy	3,355,339 +477	+0%	+$2.99K	﹤0.01%	1761
2021 Q4	$37.4M	Buy	3,354,862 +5,179	+0.2%	+$71.8K	﹤0.01%	1545
2021 Q3	$54.7M	Buy	3,349,683 +43,101	+1%	+$771K	﹤0.01%	1375
2021 Q2	$61.3M	Buy	3,306,582 +7,468	+0.2%	+$143K	﹤0.01%	1341
2021 Q1	$48.3M	Buy	3,299,114 +483,963	+17%	+$10.5M	﹤0.01%	1414
2020 Q4	$84.7M	Buy	+2,815,151	New	+$37.2M	0.01%	1107

Fidelity Investments's CDAK Position: Q2 2023 in Review

Fidelity Investments sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 448,539 shares — an estimated $78.3K sold.

Fidelity Investments first reported a position in CDAK in Q4 2020 and held it in 10 quarters. The position peaked at $84.7M in Q4 2020. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

Fidelity Investments reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Fidelity Investments sold 448,539 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $78.3K.
Fidelity Investments first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
Fidelity Investments's Codiak BioSciences, Inc. Common Stock position peaked at $84.7M in Q4 2020.
1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.